DFMO Reduces Cortical Infarct Volume after Middle Cerebral Artery Occlusion in the Rat
Author(s) -
Cheryl A. Muszynski,
Claudia S. Robertson,
J. Clay Goodman,
Charles M. Henley
Publication year - 1993
Publication title -
journal of cerebral blood flow and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.167
H-Index - 193
eISSN - 1559-7016
pISSN - 0271-678X
DOI - 10.1038/jcbfm.1993.131
Subject(s) - ornithine decarboxylase , ischemia , polyamine , medicine , middle cerebral artery , stroke (engine) , infarction , striatum , anesthesia , endocrinology , pharmacology , chemistry , enzyme , biochemistry , dopamine , myocardial infarction , mechanical engineering , engineering
Ornithine decarboxylase (ODC), a key enzyme in polyamine biosynthesis, is induced in ischemic tissue and may mediate vasogenic edema and delayed neuronal death. We determined the effects of α-difluoromethylornithine (DFMO), a specific inhibitor of ODC, on infarct size and ODC activity in a rat model of transient focal ischemia. DFMO blocked the ischemia-induced increase in ODC and significantly reduced infarct volumes by 57–45%, depending upon the treatment regimen. These studies suggest that polyamine metabolism plays a role in the development of cerebral infarction after focal ischemia and that DFMO may be useful in limiting injury after a stroke.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom